FDA approves first treatment to delay onset of type 1 diabetes | CNN
CNN — A biologic therapy that delays the onset of type 1 diabetes received approval from the U.S. Food and Drug Administration on Thursday. It is the first therapy approved for the prevention of type 1 diabetes. The monoclonal antibody teplizumab, which will be marketed under the brand name Tzield, from ProventionBio and Sanofi is …
FDA approves first treatment to delay onset of type 1 diabetes | CNN Read More »
